[go: up one dir, main page]

WO2009127073A1 - Cosmetic preparation tailored to an individual and method for the production thereof - Google Patents

Cosmetic preparation tailored to an individual and method for the production thereof Download PDF

Info

Publication number
WO2009127073A1
WO2009127073A1 PCT/CH2008/000179 CH2008000179W WO2009127073A1 WO 2009127073 A1 WO2009127073 A1 WO 2009127073A1 CH 2008000179 W CH2008000179 W CH 2008000179W WO 2009127073 A1 WO2009127073 A1 WO 2009127073A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic
individual
sample
product
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CH2008/000179
Other languages
German (de)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEN SOD2 FOUNDATION
Original Assignee
GEN SOD2 FOUNDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEN SOD2 FOUNDATION filed Critical GEN SOD2 FOUNDATION
Priority to PCT/CH2008/000179 priority Critical patent/WO2009127073A1/en
Publication of WO2009127073A1 publication Critical patent/WO2009127073A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Definitions

  • Cosmetic preparation adapted to an individual and process for its preparation
  • the invention relates to a cosmetics preparation adapted to an individual and to a process for their preparation according to the features of the preamble of claims 1 and 6.
  • a variety of cosmetics is used to care for the human body, especially the skin, hair and nails.
  • Substances used in cosmetic products may e.g. Cleansing, protective, calming, revitalizing, stabilizing, regenerating, moisturizing, skin smoothing, deodorizing or perfuming.
  • the protective effect of a cosmetic product in an individual depends strongly on the body's own circumstances. Conventional cosmetic products are not or only insufficiently tailored to the individual needs of individual people.
  • Phase 1 and Phase 2 detoxification which primarily degrade specific environmental pollutants, but also specific mechanisms that degrade harmful by-products of endogenous metabolic processes such as free radicals, for example, to water.
  • the body's defense shows fluctuations in the effectiveness of individuals or organisms.
  • Reason for this are deviations in the DNA of organisms, which have emerged as a natural process through evolution and are called genetic polymorphisms. If such a deviation is present in a gene of a corresponding enzyme, the effect of the mechanism can be influenced.
  • This causes the organism disadvantages that affect the general well-being as well as the performance and concentration and their effects persist into the age of the organism and adversely affect this.
  • Appropriate methods of modern diagnostics can specifically detect the deviations in the mechanisms of the body's defense. It is also possible to use non-invasive methods for taking samples, such as evidence from the hair or saliva. After diagnosis, natural deficiencies of the organism can be improved by appropriate measures.
  • a sample of an individual is specifically subjected to a gene analysis.
  • a sample e.g. Saliva, urine, blood, hair or other tissues or body fluids. Polymorphisms or structural deviations of these genes (relative to a normal structure) can be detected with the standardized methods used in the gene analysis.
  • genes may be considered, of which a causal relationship or a correlation with Under or over functions of the body's defense are known.
  • weighting factors or correlation coefficients then provide a quantitative statement about the strength of the respective context. Such weighting factors can be generated empirically, for example, from results of different studies. The result of the test indicates whether and to what extent the body's own defense must be supported in order to neutralize harmful substances and / or influences and thus protect the organism.
  • the supporting measures are, above all, other non-medical measures, such as the preparation and use of suitable dietary products and skin care products, which have an influence on the natural defense mechanism.
  • the genetic analysis shows whether and to what extent there is a deviation in the DNA of the enzyme in question. If the enzyme (eg the SOD2) is involved in the decomposition of free oxygen radicals (ROS), the degradation of the ROS is slowed down or impaired. In this case, the addition of active ingredients such as vitamin C and vitamin E, which naturally reduce ROS or minerals that increase the function of S0D2 is recommended. In this case, this would be manganese or copper or zinc.
  • the enzyme eg the SOD2
  • ROS free oxygen radicals
  • tables or matrix-like representations can be used as aids, which can also be easily stored and processed electronically. In this way, e.g. values for the recommended daily allowance of different additives based on national food and / or cosmetic rights may also be stored and taken into account to determine the individual dosage of such substances as adjusted by genetic analysis.
  • Formulations for cosmetic preparations tailored to individual individuals can be prepared with the method according to the invention.
  • Such cosmetic preparations each comprise one or more cosmetic products, such as externally applicable skin creams and / or dietary supplements, which can be administered as dragees, for example.
  • These cosmetic products each comprise a foundation (as used in conventional cosmetic products) with one or more incorporated therein additives.
  • the additives in turn are usually active ingredients such as minerals, trace elements, vitamins, amino acids and proteins.
  • the composition of the active substance combination or its dosage or concentration is matched to the needs of the individual on the basis of the gene analysis.
  • the formulation, ie the composition and concentration or amount of the individual active ingredients can be carried out, for example, empirically by a specialist.
  • a computer which calculates the suitable active ingredients and their dosages on the basis of predefinable functions and / or plausibility criteria.
  • individual cosmetic preparations can be prepared fully automatically by means of a DNA analysis.
  • the individual cosmetic products are packed in suitable containers such as blister packs, cans or tubes and marked individually (eg name, first name and insurant number), whereby the identification allows a clear reference to the person from whom the sample originates.
  • the gene analysis can be independent of the
  • Cosmetic preparation can be made by a suitably equipped laboratory. Preferably, however, the analysis process is carried out at the production site. In this way, data obtained from the analysis process can be forwarded directly to the manufacturing process and a high degree of automation can be achieved.
  • Cosmetic preparations of the above type are preferably used for skin and / or hair care.
  • the cosmetic products may contain one or more additives or active ingredients from the following, non-exhaustive list of additives or active ingredients:
  • ROS Free oxygen radicals
  • the sample is a person provided with the test subject's saliva. At the sample entry, this is recorded and marked with a code. The code and the detected
  • the islolated DNA of the test person serves as a so-called template for the investigation of the relevant gene segment in which the polymorphism is located.
  • the investigation is carried out with the Polymerase Chain Reaction (PCR) with common
  • the result determines the concentration and composition of the cosmetic products. If the test result is negative (both maternal and father alleles show no variance), the resulting enzyme (which may be responsible, for example, for the degradation of free oxygen radicals) has a normal function. The contents of the cosmetic products in this case do not require a high concentration or specific composition to aid in the breakdown of free oxygen radicals.
  • a suitable for this finding cosmetic preparation can eg daily supplement with manganese (4mg), acerola juice (up to 30mg), vitamin C (50% of the recommended daily dose), vitamin E (10mg or 100% of the recommended daily dose), L-carnitine (100mg), copper (2mg) , Zinc (7.5mg), magnesium (75mg), coenzyme QlO (7.5mg) and a cream containing manganese (0.0001), coenzyme QlO (0.01), superoxide dismutase (0.01), vitamin C (0.01), daucus carota oil (0.01 ), Tocopherol (0.2) (percentages in% QSP 100).
  • a positive result of the test in the present example indicates that ROS are not degraded fast enough or not completely by the carrier, so that these ROS attack and damage the body's own cell components.
  • these weak points of the body's mechanism can be compensated.
  • manganese, copper and zinc are mentioned, which are cofactors of SOD 1 & 2 and ensure the function of these enzymes.
  • Vit. C, Vit. E and ubiquinone are also directly involved in the breakdown of ROS.
  • the minerals, trace elements, vitamins, in addition, but also during the degradation supporting amino acids and proteins, can also be taken as supplements to the food be used, or for the protection of the skin in a suitable dosage as constituents of creams.
  • the weight data refer to dietary supplements and the percentage data for externally applicable cosmetic products:

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)

Abstract

A cosmetic preparation comprises one or more cosmetic products tailored to an individual. The tailoring of the cosmetic products to the individual is carried out in that a genetic analysis of a sample of the individual is performed, and in that based on the result of said genetic analysis suitable additives or active substances are metered to a base product.

Description

Auf ein Individuum abgestimmte Kosmetikzubereitung und Verfahren zu deren Herstellung Cosmetic preparation adapted to an individual and process for its preparation

Gegenstand der Erfindung ist eine auf ein Individuum abgestimmte Kosmetikzubereitung sowie ein Verfahren zu deren Herstellung gemäss den Merkmalen des Oberbegriffs der Ansprüche 1 und 6.The invention relates to a cosmetics preparation adapted to an individual and to a process for their preparation according to the features of the preamble of claims 1 and 6.

Eine Vielzahl von Kosmetika dient der Pflege des menschlichen Körpers, insbesondere der Haut, der Haare und Nägel. Bei Kosmetikprodukten verwendete Substanzen können z.B. reinigend, schützend, beruhigend, vitalisierend, stabilisierend, regenerierend, feuchtigkeitsspendend, hautglättend, deodorierend oder parfümierend wirken. Die Schutzwirkung eines Kosmetikproduktes bei einem Individuum hängt stark von dessen körpereigenen Gegebenheiten ab. Herkömmliche Kosmetikprodukte sind nicht oder nur ungenügend auf individuelle Ansprüche einzelner Personen abgestimmt.A variety of cosmetics is used to care for the human body, especially the skin, hair and nails. Substances used in cosmetic products may e.g. Cleansing, protective, calming, revitalizing, stabilizing, regenerating, moisturizing, skin smoothing, deodorizing or perfuming. The protective effect of a cosmetic product in an individual depends strongly on the body's own circumstances. Conventional cosmetic products are not or only insufficiently tailored to the individual needs of individual people.

Es ist deshalb Aufgabe der vorliegenden Erfindung, eine Kosmetikzubereitung und ein Verfahren zu deren Herstellung zu schaffen, welche an individuelle Bedürfnisse einer Person angepasst sind. Diese Aufgabe wird gelöst durch eine auf ein Individuum abgestimmte Kosmetikzubereitung mit mindestens einem Kosmetikprodukt und durch ein Verfahren zur Herstellung einer auf ein Individuum abgestimmten Kosmetikzubereitung gemäss den Merkmalen der Ansprüche 1 und 6.It is therefore an object of the present invention to provide a cosmetic preparation and a process for their preparation, which are adapted to individual needs of a person. This object is achieved by a cosmetics preparation tailored to an individual with at least one cosmetic product and by a process for producing a cosmetics preparation tailored to an individual according to the features of claims 1 and 6.

Gene enthalten fundamentale Informationen über natürliche körpereigene Abwehrmechanismen eines Organismus. Diese Abwehrmechanismen schützen den Organismus vor schädlichen Einflüssen. Dazu zählen externe oder interne Schadstoffe bzw. Chemikalien aller Art, die z.B. aufgrund natürlicher oder industrieller Prozesse in die Umwelt des Organismus gelangen, über Nahrungsmittel oder Arzneimittel vom Körper aufgenommen oder als Nebenprodukte von körpereigenen Stoffwechselvorgängen entstehen können. Um diesen Schadstoffen zu begegnen besitzt der Körper eigene, natürliche Abwehrmechanismen in Form von Proteinen bzw. Enzymen. Der spezifische Aufbau dieser Abwehrmechanismen ist in den Genen jedes Organismus festgelegt. Dabei handelt es sich um verschiedenste Formen von Mechanismen wie z.B. die Phase-1 und Phase-2-Entgiftung, die vor allem spezifische Umweltschadstoffe abbaut, aber auch spezifische Mechanismen, die schädliche Nebenprodukte von körpereigenen Stoffwechselvorgängen wie freie Radikale z.B. zu Wasser abbauen. Die körpereigene Abwehr zeigt aber bei einzelnen Personen bzw. Organismen Schwankungen in Ihrer Wirksamkeit auf. Grund dafür sind Abweichungen in der DNA der Organismen, welche als natürlicher Vorgang durch die Evolution entstanden sind und als genetische Polymorphismen bezeichnet werden. Liegt eine solche Abweichung in einem Gen eines entsprechenden Enzyms vor, kann die Wirkung des Mechanismus beeinflusst werden. Dadurch entstehen dem Organismus Nachteile, welche das allgemeine Wohlbefinden sowie die Leistung und Konzentration beeinflussen und deren Auswirkungen bis ins Alter des Organismus anhalten und diesen nachteilig beeinflussen. Durch geeignete Methoden der modernen Diagnostik lassen sich jedoch die Abweichungen in den Mechanismen der körpereigenen Abwehr gezielt nachweisen. Dabei lassen sich auch nicht-invasive Methoden zur Probenentnahme anwenden, wie z.B. Nachweise aus dem Haar oder dem Speichel. Nach erfolgter Diagnostik lassen sich natürliche Schwachstellen des Organismus durch geeignete Maßnahmen verbessern.Genes contain fundamental information about the body's natural defense mechanisms. These defense mechanisms protect the organism from harmful influences. These include external or internal pollutants or chemicals of all kinds, which, for example, due to natural or industrial processes into the environment of the organism, via food or drugs absorbed by the body or may be produced as by-products of the body's metabolic processes. To counter these pollutants, the body has its own, natural defense mechanisms in the form of proteins or enzymes. The specific structure of these defense mechanisms is defined in the genes of each organism. These are various forms of mechanisms, such as Phase 1 and Phase 2 detoxification, which primarily degrade specific environmental pollutants, but also specific mechanisms that degrade harmful by-products of endogenous metabolic processes such as free radicals, for example, to water. However, the body's defense shows fluctuations in the effectiveness of individuals or organisms. Reason for this are deviations in the DNA of organisms, which have emerged as a natural process through evolution and are called genetic polymorphisms. If such a deviation is present in a gene of a corresponding enzyme, the effect of the mechanism can be influenced. This causes the organism disadvantages that affect the general well-being as well as the performance and concentration and their effects persist into the age of the organism and adversely affect this. Appropriate methods of modern diagnostics, however, can specifically detect the deviations in the mechanisms of the body's defense. It is also possible to use non-invasive methods for taking samples, such as evidence from the hair or saliva. After diagnosis, natural deficiencies of the organism can be improved by appropriate measures.

Erfindungsgemäss wird eine Probe eines Individuums gezielt einer Genanalyse unterzogen. Als Probe können z.B. Speichel, Urin, Blut, Haare bzw. andere Gewebe oder Körperflüssigkeiten verwendet werden. Mit den bei der Genanalyse angewendeten standardisierten Verfahren können Polymorphismen bzw. Strukturabweichungen dieser Gene (bezogen auf eine Normalstruktur) erfasst werden.According to the invention, a sample of an individual is specifically subjected to a gene analysis. As a sample, e.g. Saliva, urine, blood, hair or other tissues or body fluids. Polymorphisms or structural deviations of these genes (relative to a normal structure) can be detected with the standardized methods used in the gene analysis.

Insbesondere können dabei Gene berücksichtigt werden, von denen ein Kausalzusammenhang oder eine Korrelation mit Unter- oder Überfunktionen der körpereigenen Abwehr bekannt sind.In particular, genes may be considered, of which a causal relationship or a correlation with Under or over functions of the body's defense are known.

Als Hilfsmittel zum Ermitteln der Kapazität eines Organismus zur Abwehr schädlicher Einflüsse und/oder Substanzen können z.B. bekannte Gen-Polymorphismen einerseits und bekannte schädliche Einflüsse und/oder Substanzen andererseits in einer Matrix oder Tabelle einander gegenübergestellt werden. Gewichtungsfaktoren bzw. Korrelationskoeffizienten liefern dann eine quantitative Aussage über die Stärke des jeweiligen Zusammenhangs. Solche Gewichtungsfaktoren können z.B. empirisch aus Resultaten unterschiedlicher Studien generiert werden. Das Resultat der Testung zeigt an, ob und in welchem Umfang die körpereigene Abwehr unterstützt werden muss, um schädliche Substanzen und/oder Einflüsse zu neutralisieren und so den Organismus zu schützen. Bei den unterstützenden Maßnahmen handelt es sich nebst geeigneten Bewegungsübungen vor allem um andere nicht-medizinische Massnahmen wie die Erstellung und Anwendung geeigneter diätetischer Mittel sowie Hautpflegemittel, die auf den natürlichen Abwehrmechanismus einen Einfluss haben. Die genetische Analyse zeigt, ob und in welchem Umfang eine Abweichung in der DNA des betreffenden Enzyms vorliegt. Ist das Enzym (z.B. die SOD2) beim Abbau freier Sauerstoffradikale (ROS) involviert, so ist bei einer Abweichung der Abbau der ROS verlangsamt bzw. beeinträchtigt. In diesem Falle empfiehlt sich die Zugabe von Wirkstoffen wie Vitamin C und Vitamin E, welche von Natur aus ROS abbauen bzw. Mineralien, welche die Funktion der S0D2 steigern. In diesem Falle wäre dies Mangan bzw. Kupfer oder Zink.As an aid for determining the capacity of an organism to ward off harmful influences and / or substances, known genetic polymorphisms, on the one hand, and known harmful influences and / or substances, on the other hand, can be contrasted in a matrix or table. Weighting factors or correlation coefficients then provide a quantitative statement about the strength of the respective context. Such weighting factors can be generated empirically, for example, from results of different studies. The result of the test indicates whether and to what extent the body's own defense must be supported in order to neutralize harmful substances and / or influences and thus protect the organism. In addition to suitable exercises, the supporting measures are, above all, other non-medical measures, such as the preparation and use of suitable dietary products and skin care products, which have an influence on the natural defense mechanism. The genetic analysis shows whether and to what extent there is a deviation in the DNA of the enzyme in question. If the enzyme (eg the SOD2) is involved in the decomposition of free oxygen radicals (ROS), the degradation of the ROS is slowed down or impaired. In this case, the addition of active ingredients such as vitamin C and vitamin E, which naturally reduce ROS or minerals that increase the function of S0D2 is recommended. In this case, this would be manganese or copper or zinc.

Zur Ermittlung geeigneter anzuwendender Substanzen und deren Dosierung in Abhängigkeit der mit der Genanalyse erfassten Genpolymorphismen bzw. der damit verbundenen Beeinträchtigungen können als Hilfsmittel Tabellen bzw. matrixartige Darstellungen benutzt werden, welche auch leicht elektronisch gespeichert und verarbeitet werden können. Auf diese Weise können z.B. auch auf nationalen Lebensmittel- und/oder Kosmetikrechten beruhende Werte für die empfohlene Tagesdosis unterschiedlicher Zusatzstoffe gespeichert und berücksichtigt werden, um die anhand der Genanalyse angepasste individuelle Dosierung solcher Substanzen zu bestimmen.To determine suitable substances to be used and their dosage as a function of the gene polymorphisms detected by the gene analysis or the impairments associated therewith, tables or matrix-like representations can be used as aids, which can also be easily stored and processed electronically. In this way, e.g. values for the recommended daily allowance of different additives based on national food and / or cosmetic rights may also be stored and taken into account to determine the individual dosage of such substances as adjusted by genetic analysis.

Mit dem erfindungsgemässen Verfahren können Rezepturen für auf einzelne Individuen abgestimmte Kosmetikzubereitungen erstellt werden. Solche Kosmetikzubereitungen umfassen jeweils ein oder mehrere Kosmetikprodukte wie z.B. äusserlich anwendbare Hautcremes und/oder diätetische Nahrungsergänzungsmittel, die z.B. als Dragees verabreicht werden können. Diese Kosmetikprodukte umfassen jeweils eine Grundlage (wie sie auch bei herkömmlichen Kosmetikprodukten verwendet wird) mit einem oder mehreren darin eingearbeiteten Zusatzstoffen. Die Zusatzstoffe wiederum sind in der Regel Wirkstoffe wie Mineralien, Spurenelemente Vitamine, Aminosäuren und Proteine. Die Zusammensetzung der Wirkstoffkombination bzw. deren Dosierung oder Konzentration wird anhand der Genanalyse auf die Bedürfnisse des jeweiligen Individuums abgestimmt. Die Rezeptur, also die Zusammensetzung und Konzentration bzw. Menge der einzelnen Wirkstoffe kann z.B. empirisch durch eine Fachperson vorgenommen werden. Alternativ kann auch ein Computer eingesetzt werden, der anhand vorgebbarer Funktionen und/oder Plausibilitätskriterien die geeigneten Wirkstoffe und deren Dosierung berechnet. In diesem Fall können individuelle Kosmetikzubereitungen anhand einer DNA-Analyse vollautomatisch hergestellt werden. Die einzelnen Kosmetikprodukte werden in geeigneten Gebinden wie Blister-Packungen, Dosen oder Tuben verpackt und individuell gekennzeichnet (z.B. Name, Vorname und Versichertennummer) , wobei die Kennzeichnung einen eindeutigen Bezug zur Person ermöglicht, von der die Probe stammt. Die Genanalyse kann unabhängig von derFormulations for cosmetic preparations tailored to individual individuals can be prepared with the method according to the invention. Such cosmetic preparations each comprise one or more cosmetic products, such as externally applicable skin creams and / or dietary supplements, which can be administered as dragees, for example. These cosmetic products each comprise a foundation (as used in conventional cosmetic products) with one or more incorporated therein additives. The additives in turn are usually active ingredients such as minerals, trace elements, vitamins, amino acids and proteins. The composition of the active substance combination or its dosage or concentration is matched to the needs of the individual on the basis of the gene analysis. The formulation, ie the composition and concentration or amount of the individual active ingredients can be carried out, for example, empirically by a specialist. Alternatively, it is also possible to use a computer which calculates the suitable active ingredients and their dosages on the basis of predefinable functions and / or plausibility criteria. In this case, individual cosmetic preparations can be prepared fully automatically by means of a DNA analysis. The individual cosmetic products are packed in suitable containers such as blister packs, cans or tubes and marked individually (eg name, first name and insurant number), whereby the identification allows a clear reference to the person from whom the sample originates. The gene analysis can be independent of the

Produktion der Kosmetikzubereitung von einem entsprechend ausgerüsteten Labor vorgenommen werden. Vorzugsweise wird aber der Analyseprozess am Produktionsstandort durchgeführt. Auf diese Weise können Daten, die aus dem Analyseprozess gewonnen werden, unmittelbar an den Herstellprozess weitergeleitet und ein hoher Automatisierungsgrad erreicht werden. Kosmetikzubereitungen der oben genannten Art werden vorzugsweise zur Haut- und/oder Haarpflege verwendet. Die Kosmetikprodukte können einen oder mehrere Zusatzoder Wirkstoffe aus der folgenden, nicht abschliessenden Aufzählung von Zusatz- oder Wirkstoffen enthalten:Production of the cosmetic preparation can be made by a suitably equipped laboratory. Preferably, however, the analysis process is carried out at the production site. In this way, data obtained from the analysis process can be forwarded directly to the manufacturing process and a high degree of automation can be achieved. Cosmetic preparations of the above type are preferably used for skin and / or hair care. The cosmetic products may contain one or more additives or active ingredients from the following, non-exhaustive list of additives or active ingredients:

Mangan, Kupfer, Zink, Magnesium, Vit. A, Vit. C, Vit. E, Ubichinon oder Coenzym QlO, Daucus Carota OiI, Sodium DNA, Beta Karotin, Palmitoyl pentapeptide 4 oder Matrixyl, Polysorbat 20, Dextrin, Simmondsia Chinensis OiI. Anhand eines Beispiels (Messung des körpereigenenManganese, Copper, Zinc, Magnesium, Vit. A, Vit. C, Vit. E, Ubiquinone or Coenzyme Q10, Daucus Carota OiI, Sodium DNA, Beta Carotene, Palmitoyl pentapeptide 4 or Matrixyl, Polysorbate 20, Dextrin, Simmondsia Chinensis OiI. Using an example (measurement of the body's own

Mechanismus zum Abbau freier Sauerstoffradikale) wird die Erfindung nachfolgend genauer erläutert:Mechanism for reducing free oxygen radicals), the invention is explained in more detail below:

Freie Sauerstoffradikale (ROS) werden in der Literatur als Ursache für Zellschädigungen angesehen, die insbesondere bei Sport aber auch im "Wellnessbereich" und der Kosmetik eine bedeutende Rolle spielen und verantwortlich für Leistungsabfall bzw. Hautalterung und als Ursache zur Einleitung degenerativer Prozesse des Körpers angesehen werden. Jeder Organismus hat für den Abbau der ROS einen Mechanismus entwickelt, wobei die Enzym Superoxiddismutase 1 und 2 (SOD 1 &2) eine bedeutende Rolle bei diesem Mechanismus spielen, indem diese das ROS unmittelbar für den Abbau vorbereiten. Die SOD 1 & 2 sind genetisch codiert. Es konnte gezeigt werden dass einzelne Organismen hier eine durch die Evolution verursachte genetische Abweichung besitzen (genetischer Polymorphismus) . Träger dieser Abweichungen können durch einen einfachen genetischen Test bestimmt werden, der nachfolgend kurz beschrieben ist:Free oxygen radicals (ROS) are considered in the literature as the cause of cell damage, which play a significant role in sports but also in the "wellness" and cosmetics and responsible for performance degradation or skin aging and as a cause for initiating degenerative processes of the body , Each organism has developed a mechanism for the degradation of ROS, with the enzyme superoxide dismutase 1 and 2 (SOD 1 & 2) playing an important role in this mechanism by preparing the ROS directly for degradation. The SOD 1 & 2 are genetically coded. It could be shown that individual organisms possess a genetic deviation caused by evolution (genetic polymorphism). Carriers of these deviations can by a simple genetic test, which is briefly described below:

Als Probe dient ein mit Speichel der Testperson versehenes Päd. Beim Probeneingang wird dieses erfasst und mit einem Code gekennzeichnet. Der Code und die erfasstenThe sample is a person provided with the test subject's saliva. At the sample entry, this is recorded and marked with a code. The code and the detected

Personendaten werden elektronisch gespeichert. In einem nächsten Schritt wird aus dem auf dem Päd befindlichen getrockneten Speichel die betreffende DNA der Testperson für die genetische Testung isoliert. Dabei wird ein gängiges Standardverfahren angewendet. Es folgt diePersonal data is stored electronically. In a next step, the DNA of the test subject for genetic testing is isolated from the dried saliva on the pediatric. A common standard procedure is used. It follows the

Bestimmung des genetischen Polymorphismus. Dabei dient die islolierte DNA der Testperson als sog. Template zur Untersuchung des relevanten Genabschnittes, in dem sich der Polymorphismus befindet. Die Untersuchung erfolgt mit der Polymerase Chain Reaction (PCR) mit gängigenDetermination of genetic polymorphism. In this case, the islolated DNA of the test person serves as a so-called template for the investigation of the relevant gene segment in which the polymorphism is located. The investigation is carried out with the Polymerase Chain Reaction (PCR) with common

Startsequenzen wie in der Literatur beschrieben. Anhand des Ergebnisses werden Konzentration und Zusammensetzung der Kosmetikprodukte bestimmt. Ist das Testergebnis negativ (beide Allele von Mutter und Vater weisen keine Abweichung auf) , hat das resultierende Enzym (dieses kann z.B. für den Abbau freier Sauerstoffradikale verantwortlich sein) eine normale Funktion. Die Inhalte der Kosmetikprodukte erfordern in diesem Fall keine hohe Konzentration oder spezifische Zusammensetzung zur Unterstützung beim Abbau freierStarting sequences as described in the literature. The result determines the concentration and composition of the cosmetic products. If the test result is negative (both maternal and father alleles show no variance), the resulting enzyme (which may be responsible, for example, for the degradation of free oxygen radicals) has a normal function. The contents of the cosmetic products in this case do not require a high concentration or specific composition to aid in the breakdown of free

Sauerstoffradikale durch das betreffende Enzym. Eine für diesen Befund geeignete Kosmetikzubereitung kann z.B. ein täglich einzunehmendes Nahrungsergänzungsmittel mit Mangan (4mg), Acerolasaft (dosiert bis 30mg), Vitamin C (50% der empfohlenen Tagesdosis) , Vitamin E (10mg bzw. 100% der empfohlenen Tagesdosis) , L-Carnitin (100mg) , Kupfer (2mg) , Zink (7.5mg), Magnesium (75mg), Coenzym QlO (7.5mg) und eine Creme mit Mangan (0.0001), Coenzym QlO (0.01), Superoxyde Dismutase (0.01), Vitamin C (0.01), Daucus carota oil (0.01), Tocopherol (0.2) umfassen (Anteile in % QSP 100) .Oxygen radicals by the enzyme in question. A suitable for this finding cosmetic preparation can eg daily supplement with manganese (4mg), acerola juice (up to 30mg), vitamin C (50% of the recommended daily dose), vitamin E (10mg or 100% of the recommended daily dose), L-carnitine (100mg), copper (2mg) , Zinc (7.5mg), magnesium (75mg), coenzyme QlO (7.5mg) and a cream containing manganese (0.0001), coenzyme QlO (0.01), superoxide dismutase (0.01), vitamin C (0.01), daucus carota oil (0.01 ), Tocopherol (0.2) (percentages in% QSP 100).

Ein positiver Befund des Tests im vorliegenden Beispiel zeigt an, dass ROS nicht schnell genug bzw. nicht in vollem umfang vom Träger abgebaut werden, so dass diese ROS körpereigene Zellbestandteile angreifen und diese schädigen. Durch Erstellung besonderer Diätempfehlungen bzw. durch Zugabe spezifischer Mineralien oder Vitamine lassen sich jedoch diese Schwachstellen des körpereigenen Mechanismus ausgleichen. Als Beispiele werden in diesem Fall Mangan, Kupfer und Zink genannt, die Kofaktoren der SOD 1 & 2 sind und die Funktion dieser Enzyme gewährleisten. Zudem empfiehlt es sich zusätzlich noch Vit. C, Vit. E, sowie Ubichinon einzunehmen, da diese direkt auch am Abbau von ROS beteiligt sind. Die Mineralien, Spurenelemente, Vitamine, zusätzlich aber auch beim Abbau unterstützende Aminosäuren und Proteine, können als Supplemente ebenfalls zu der Nahrung eingenommen werden, bzw. zum Schutz der Haut in geeigneter Dosierung als Bestandteile von Cremes aufgetragen werden. Nachfolgend sind bevorzugte Dosierungsbereiche für einige Zusatzstoffe angegeben. Die Gewichtsangaben beziehen sich auf Nahrungsergänzungsmittel und die prozentualen Angaben auf äusserlich anwendbare Kosmetikprodukte:A positive result of the test in the present example indicates that ROS are not degraded fast enough or not completely by the carrier, so that these ROS attack and damage the body's own cell components. By creating special dietary recommendations or by adding specific minerals or vitamins, however, these weak points of the body's mechanism can be compensated. As examples in this case manganese, copper and zinc are mentioned, which are cofactors of SOD 1 & 2 and ensure the function of these enzymes. In addition, it is also recommended to take Vit. C, Vit. E and ubiquinone, as these are also directly involved in the breakdown of ROS. The minerals, trace elements, vitamins, in addition, but also during the degradation supporting amino acids and proteins, can also be taken as supplements to the food be used, or for the protection of the skin in a suitable dosage as constituents of creams. The following are preferred dosage ranges for some additives. The weight data refer to dietary supplements and the percentage data for externally applicable cosmetic products:

Mangan: 0.05mg - 30mg 0.0005% - 6%Manganese: 0.05mg - 30mg 0.0005% - 6%

Kupfer: 0.05mg - 30mg 0.0005% - 6% Zink: 0.05mg - 30mg 0.0005% - 6%Copper: 0.05mg - 30mg 0.0005% - 6% Zinc: 0.05mg - 30mg 0.0005% - 6%

Vit. C: 1mg - 5g 0.0005% - 10%Vit. C: 1mg - 5g 0.0005% - 10%

Vit. E: 1mg - 5g 0.0005% - 10%Vit. E: 1mg - 5g 0.0005% - 10%

Ubichinon: 0.005mg - 3g 0.0005% - 5% Ubiquinone: 0.005mg - 3g 0.0005% - 5%

Claims

Patentansprüche claims 1. Auf ein Individuum abgestimmte Kosmetikzubereitung mit mindestens einem Kosmetikprodukt, wobei dieses1. An individualized cosmetic preparation with at least one cosmetic product, this one Kosmetikprodukt eine Grundlage mit mindestens einem entsprechend einer Rezeptur in die Grundlage eingearbeiteten Zusatzstoff umfasst, dadurch gekennzeichnet, dass die Rezeptur des Kosmetikprodukts anhand einer Genanalyse einer Probe des Individuums an individuelle Bedürfnisse des Individuums angepasst ist.Cosmetic product comprises a base with at least one according to a recipe incorporated into the base additive, characterized in that the formulation of the cosmetic product is adapted based on a genetic analysis of a sample of the individual to individual needs of the individual. 2. Kosmetikzubereitung nach Anspruch 1, dadurch gekennzeichnet, dass das Kosmetikprodukt ein äusserlich anwendbares Pflegemittel mit einem oder mehreren Zusatzstoffen aus folgenden Gruppen von Zusatzstoffen ist: Mineralien, Spurenelemente, Vitamine, Aminosäuren, Proteine, organische chemische Verbindungen.2. Cosmetic preparation according to claim 1, characterized in that the cosmetic product is an externally applicable care product with one or more additives from the following groups of additives: minerals, trace elements, vitamins, amino acids, proteins, organic chemical compounds. 3. Kosmetikzubereitung nach Anspruch 1, dadurch gekennzeichnet, dass das Kosmetikprodukt ein Nahrungsergänzungsmittel mit einem oder mehreren Zusatzstoffen aus folgenden Gruppen von Zusatzstoffen ist: Mineralien, Spurenelemente, Vitamine, Aminosäuren, Proteine, organische chemische Verbindungen .3. A cosmetic preparation according to claim 1, characterized in that the cosmetic product is a dietary supplement with one or more additives from the following groups of additives: minerals, trace elements, vitamins, amino acids, proteins, organic chemical Links . 4. Kosmetikzubereitung nach einem der Ansprüche 1 bis 3, wobei diese Kosmetikzubereitung mindestens zwei Kosmetikprodukte umfasst, dadurch gekennzeichnet, dass eines dieser Kosmetikprodukte ein äusserlich anwendbares Pflegemittel ist, und dass eines dieser Kosmetikprodukte ein Nahrungsergänzungsmittel ist.4. Cosmetic preparation according to one of claims 1 to 3, wherein said cosmetic preparation comprises at least two cosmetic products, characterized in that one of these cosmetic products is an externally applicable care product, and that one of these cosmetic products is a dietary supplement. 5. Kosmetikzubereitung nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass das oder die Kosmetikprodukte in individuell gekennzeichneten Gebinden verpackt sind.5. Cosmetic preparation according to one of claims 1 to 4, characterized in that the or the cosmetic products are packaged in individually labeled containers. 6. Verfahren zur Herstellung einer auf ein Individuum abgestimmten Kosmetikzubereitung mit mindestens einem Kosmetikprodukt, gekennzeichnet durch folgende Verfahrensschritte a) Bereitstellung einer Probe des Individuums b) Durchführung einer Genanalyse dieser Probe und6. A method for producing a personalized to a individual cosmetic preparation with at least one cosmetic product, characterized by the following process steps a) providing a sample of the individual b) performing a genetic analysis of this sample and Ermittlung individueller genetischer Merkmale der Probe c) Zusammenstellung einer an die individuellen genetischen Merkmale der Probe angepassten Rezeptur für das Kosmetikprodukt bzw. für die Kosmetikprodukte d) Herstellung des Kosmetikproduktes bzw. derDetermination of individual genetic characteristics of the sample c) Compilation of a formulation adapted to the individual genetic characteristics of the sample for the cosmetic product or for the cosmetic products d) production of the cosmetic product or the Kosmetikprodukte gemäss der individuell angepassten RezepturCosmetic products according to the individually adapted recipe 7. Verfahren nach Anspruch 6, dadurch gekennzeichnet, dass bei der Genanalyse Speichel, Urin, Blut, Haare oder andere Gewebe oder Körperflüssigkeiten des Individuums als Probe verwendet wird.7. The method according to claim 6, characterized in that the gene analysis saliva, urine, blood, hair or other tissues or body fluids of the individual is used as a sample. 8. Verfahren nach einem der Ansprüche 6 oder 7, dadurch gekennzeichnet, dass bei der Genanalyse Gene berücksichtigt werden, deren Polymorphismen mit Funktionen der körpereigenen Abwehr korrelieren. 8. The method according to any one of claims 6 or 7, characterized in that genes are considered in the gene analysis, the polymorphisms correlate with functions of the body's defense.
PCT/CH2008/000179 2008-04-18 2008-04-18 Cosmetic preparation tailored to an individual and method for the production thereof Ceased WO2009127073A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CH2008/000179 WO2009127073A1 (en) 2008-04-18 2008-04-18 Cosmetic preparation tailored to an individual and method for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2008/000179 WO2009127073A1 (en) 2008-04-18 2008-04-18 Cosmetic preparation tailored to an individual and method for the production thereof

Publications (1)

Publication Number Publication Date
WO2009127073A1 true WO2009127073A1 (en) 2009-10-22

Family

ID=40347737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2008/000179 Ceased WO2009127073A1 (en) 2008-04-18 2008-04-18 Cosmetic preparation tailored to an individual and method for the production thereof

Country Status (1)

Country Link
WO (1) WO2009127073A1 (en)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066327A (en) * 1997-12-17 2000-05-23 Color Access, Inc. Antioxidant mixture
WO2002080755A2 (en) * 2001-04-05 2002-10-17 Genelink, Inc. Kits and methods for assessing oxidative stress
WO2003086329A2 (en) * 2002-04-09 2003-10-23 The Boots Company Plc Skincare compositions comprising anti-oxidant agents
WO2004026107A2 (en) * 2002-09-20 2004-04-01 Genelink, Inc. Kits and methods for assessing skin health
WO2004033725A2 (en) * 2002-10-08 2004-04-22 Sciona Limited Methods and means for the treatment of inflammatory disorders involving genotyping of the 5, 10- methylenetetrahydrofolate reductase (mthfr) gene
US20050281889A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for adults
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
CN1858258A (en) * 2006-04-07 2006-11-08 安迈利科技发展(北京)有限公司 Skin Beauty and Health Care Method Based on Gene Polymorphism
US20070071871A1 (en) * 2005-09-28 2007-03-29 Shrikhande Anil J Grape extract, dietary supplement thereof, and processes therefor
EP1800675A1 (en) * 2005-12-23 2007-06-27 Nutricia N.V. Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
US20070184153A1 (en) * 2006-02-03 2007-08-09 Prasad Kedar N Multiple antioxidant optimal health/veterans ultimate complete formulations
FR2897513A1 (en) * 2006-02-20 2007-08-24 Macanthy Sa Lab COMPOSITION FOR ORAL ADMINISTRATION SUPPLEMENT FOR ACNE PREVENTION AND PHOTOPROTECTION
FR2899768A1 (en) * 2006-04-14 2007-10-19 Juva Sante Soc Par Actions Sim Food supplement, useful as antioxidant, to improve the organ response or prevent the oxidative stress and to reduce aging, comprises gamma-tocopherol, flavonoids, carnosic acid and carnosol
DE102006038758A1 (en) * 2006-04-25 2007-10-31 Christine Schrammek Kosmetik Gmbh & Co. Kg Use of a skin cream and dietary supplements

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066327A (en) * 1997-12-17 2000-05-23 Color Access, Inc. Antioxidant mixture
WO2002080755A2 (en) * 2001-04-05 2002-10-17 Genelink, Inc. Kits and methods for assessing oxidative stress
WO2003086329A2 (en) * 2002-04-09 2003-10-23 The Boots Company Plc Skincare compositions comprising anti-oxidant agents
WO2004026107A2 (en) * 2002-09-20 2004-04-01 Genelink, Inc. Kits and methods for assessing skin health
WO2004033725A2 (en) * 2002-10-08 2004-04-22 Sciona Limited Methods and means for the treatment of inflammatory disorders involving genotyping of the 5, 10- methylenetetrahydrofolate reductase (mthfr) gene
US20050281889A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for adults
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
US20070071871A1 (en) * 2005-09-28 2007-03-29 Shrikhande Anil J Grape extract, dietary supplement thereof, and processes therefor
EP1800675A1 (en) * 2005-12-23 2007-06-27 Nutricia N.V. Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
US20070184153A1 (en) * 2006-02-03 2007-08-09 Prasad Kedar N Multiple antioxidant optimal health/veterans ultimate complete formulations
FR2897513A1 (en) * 2006-02-20 2007-08-24 Macanthy Sa Lab COMPOSITION FOR ORAL ADMINISTRATION SUPPLEMENT FOR ACNE PREVENTION AND PHOTOPROTECTION
CN1858258A (en) * 2006-04-07 2006-11-08 安迈利科技发展(北京)有限公司 Skin Beauty and Health Care Method Based on Gene Polymorphism
FR2899768A1 (en) * 2006-04-14 2007-10-19 Juva Sante Soc Par Actions Sim Food supplement, useful as antioxidant, to improve the organ response or prevent the oxidative stress and to reduce aging, comprises gamma-tocopherol, flavonoids, carnosic acid and carnosol
DE102006038758A1 (en) * 2006-04-25 2007-10-31 Christine Schrammek Kosmetik Gmbh & Co. Kg Use of a skin cream and dietary supplements

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 14 November 2006 (2006-11-14), ZHEN, ERZHEN: "Cosmetic and health-care method for skin based on single nucleotide polymorphism", XP002516020, retrieved from STN Database accession no. 2006:1192237 *

Similar Documents

Publication Publication Date Title
DE69634655T2 (en) Use of a physiologically functional food to improve and / or strengthen brain function, learning ability and memory function
DE69634404T2 (en) CAROTEINOID NICOTINAMIDE ZINC COMPOSITIONS AND METHOD FOR TREATMENT USING THE SAME
DE69629813T2 (en) ORAL FIXED DIAGNOSTIC MEAL AND METHOD FOR THEIR USE
EP1562613B1 (en) Nadh/nadph-containing compound
Qin et al. Patch test in Chinese in Shanghai with cosmetic allergy to cosmetic series and products
Morató et al. Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease
CN112773825A (en) Composition containing crabapple oil and application thereof in improving oxidation resistance of nerve cells and brain health
CN116763705B (en) Composition for relieving/resisting sensitivity, preparation method and application thereof
CN116637053A (en) Whitening composition suitable for sensitive muscles and application thereof
WO2009127073A1 (en) Cosmetic preparation tailored to an individual and method for the production thereof
DE68909304T2 (en) Amino acids for the treatment of neurodegenerative disorders.
Wolosik et al. The possible pre-and post-UVA radiation protective effect of Amaranth oil on human skin fibroblast cells
EP1344058B1 (en) Kit and method for determining the redox state in urine
EP4515551A1 (en) Determining the stability of a substance or substance mixture
KR101617664B1 (en) Method of refining horse-oil, and cosmetic composition comprising the same
Butool et al. Clinical study on serum zinc levels in patients with acne vulgaris
Martić et al. Fast inverted photoprotective o/w emulsions loaded with dihydroquercetin and β-carotene: an innovative approach to in vitro assessment of antioxidant activity in a bioenvironment
CN112167494A (en) Beverage for improving hypomnesis and repairing brain injury and preparation method thereof
Boehm et al. Dermatophytose bei Hund und Katze–ein Update
Popa et al. Antagonic-stress superiority versus meclofenoxate in gerontopsychiatry (alzheimer type dementia)
Houghton et al. Effects of a gliadin-combined plant superoxide dismutase extract on self-perceived fatigue in women aged 50–65 years
DE19907878B4 (en) Process for the preparation of nutritional supplements
Jamiu et al. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences, 4-1
Dickerson et al. Dose-Ranging Study of Paraxanthine Ingestion on Cognition, Executive Function, and Psychomotor Vigilance
WO2003059091A2 (en) Use of oxygen-enriched water

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08733805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08733805

Country of ref document: EP

Kind code of ref document: A1